These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 4028625

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Transdermal therapeutic system of scopolamine (TTS-S) in the prevention of sea sickness and its mechanism of action].
    Wang E.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1990 Oct; 25(5):299-302, 319. PubMed ID: 2076342
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Transdermal scopolamine in motion sickness.
    Cronin CM, Sallan SE, Wolfe L.
    Pharmacotherapy; 1982 Oct; 2(1):29-31. PubMed ID: 6927209
    [Abstract] [Full Text] [Related]

  • 6. [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy].
    Becker G, Goossens H, Seemann K, Souchon F, Weitz T.
    Dtsch Med Wochenschr; 1984 Dec 07; 109(49):1881-5. PubMed ID: 6499689
    [Abstract] [Full Text] [Related]

  • 7. [Transdermal scopolamine (TTS-scopolamine) for the prevention of postoperative nausea and vomiting].
    Tolksdorf W, Meisel R, Müller P, Bender HJ.
    Anaesthesist; 1985 Dec 07; 34(12):656-62. PubMed ID: 4096357
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Safety of double-dose transdermal scopolamine.
    Bar R, Gil A, Tal D.
    Pharmacotherapy; 2009 Sep 07; 29(9):1082-8. PubMed ID: 19698013
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of motion sickness in parabolic flight with buccal scopolamine.
    Norfleet WT, Degioanni JJ, Calkins DS, Reschke MF, Bungo MW, Kutyna FA, Homick JL.
    Aviat Space Environ Med; 1992 Jan 07; 63(1):46-51. PubMed ID: 1550533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transdermal scopolamine, oral meclizine, and placebo in motion sickness.
    Dahl E, Offer-Ohlsen D, Lillevold PE, Sandvik L.
    Clin Pharmacol Ther; 1984 Jul 07; 36(1):116-20. PubMed ID: 6734040
    [Abstract] [Full Text] [Related]

  • 16. Preoperative transdermal hyoscine for the prevention of postoperative nausea and vomiting.
    Wilkinson AR, Frampton CM, Glover PW, Davis FM.
    Anaesth Intensive Care; 1989 Aug 07; 17(3):285-9. PubMed ID: 2774147
    [Abstract] [Full Text] [Related]

  • 17. [Effects and side effects of transdermal scopolamine for premedication in general anesthesia in elderly patients].
    Tolksdorf W, Baumann S, Heine C, Hettenbach A.
    Anasth Intensivther Notfallmed; 1986 Dec 07; 21(6):301-6. PubMed ID: 3544938
    [Abstract] [Full Text] [Related]

  • 18. Scopolamine bioavailability in combined oral and transdermal delivery.
    Nachum Z, Shahal B, Shupak A, Spitzer O, Gonen A, Beiran I, Lavon H, Eynan M, Dachir S, Levy A.
    J Pharmacol Exp Ther; 2001 Jan 07; 296(1):121-3. PubMed ID: 11123371
    [Abstract] [Full Text] [Related]

  • 19. Transdermal scopolamine reduces nausea and vomiting after outpatient laparoscopy.
    Bailey PL, Streisand JB, Pace NL, Bubbers SJ, East KA, Mulder S, Stanley TH.
    Anesthesiology; 1990 Jun 07; 72(6):977-80. PubMed ID: 2140929
    [Abstract] [Full Text] [Related]

  • 20. Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy.
    Homick JL, Kohl RL, Reschke MF, Degioanni J, Cintron-Trevino NM.
    Aviat Space Environ Med; 1983 Nov 07; 54(11):994-1000. PubMed ID: 6651736
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.